JAK2 and early-onset autosomal dominant Alzheimer disease: Zangerolamo et al. reported that the addition of TUDCA reduced inflammatory damage in the hypothalamus in Alzheimer’s disease model mice by inhibiting the activation of factors such as p-JAK2 and p-STAT3 [31].